Promotional Review. If specified in the partnership agreement and to the extent provided in such agreement, the job sharing partners may be eligible for merit promotional review provided the partner has at least three years of full-time service (or its equivalent) in the classification.
Promotional Review. After three (3) years in a classification in an agency, each employee in the unclassified service may request a review for the purpose of merit promotion to the next higher classification. Merit promotional reviews are to be conducted within thirty (30) days of the employee’s request. At least one (1) year must elapse between requests by an employee for merit promotion requests. Management reserves the right to review and promote employees prior to the completion of three (3) years of service in a classification in an agency. The merit promotional review shall be conducted by the employee’s immediate management-level supervisor, who shall submit his/her recommendation through the appropriate chain of command for review and to the agency head or his/her designee for a final decision. The results of a merit promotional review are to be stated as “Promotion” or “No Promotion.” Detailed suggestions for employee growth and improvement are to be provided with all “No Promotion” results.
Promotional Review. 18.1 XXXX Managers whose application for a promotion is unsuccessful have a right to request a review where such appointment would involve a salary increase for the applicant.
Promotional Review. BexR shall provide regulatory, medical, and legal recommendations of all promotional materials prepared by Napo with respect to the Product. The final decision on all labeling and promotional materials shall be made by Napo.
Promotional Review. 17.1 TAFE Managers whose application for a promotion is unsuccessful have a right to request a review where such appointment would involve a salary increase for the applicant.
Promotional Review. (i) If Myogen (or GSK) receives a Warning Letter from the FDA which relates to marketing, promotion, advertisement, sale or distribution of Product after the Commencement Date, or Myogen (or GSK) receives two (2) NOV's from the FDA which relate to marketing, promotion, advertisement, sale or distribution of Product after the Commencement Date, GSK will have the right to call, and Myogen will participate/or attend at its own expense, a meeting of Myogen (which will include senior level marketing and sales management of Myogen) and GSK, to be held at GSK's offices in Research Triangle Park, N.C. The purpose of such meeting will be to discuss the Promotional Materials or Promotional Activities which led to the issuance of the Warning Letter or the NOV's, as the case may be, and to discuss, if appropriate, appropriate corrective or remedial measures to Myogen's promotional review process. Subsequent to any such meeting or in lieu of such meeting (if such meeting is not held as a result of the mutual agreement of the Parties or as a result of Myogen's failure or refusal to attend), GSK may, in its sole and absolute discretion, at any time after the issuance of a Warning Letter or a second NOV from FDA related to Product after the Commencement Date, decide to invoke the promotional review procedures set forth in Section 3.2(b)(ii) below by sending written notice thereof to Myogen (hereinafter, a "Promotional Review Notice").
